UMGCCC Clinical Trials

  • More About Clinical Trials
  • Deciding to Enroll
  • Questions to Ask
  • For More Information
  • Research
  • Cancer Overviews
  • Treatment Programs
  • Physicians and Staff
Protocol SummaryBack To Search Instructions
Protocol No.EA5142Principal InvestigatorScilla, Katherine
PhasePhase III
Age GroupAdult
TitleAdjuvant Nivolumab in Resected Lung Cancers (ANVIL) - A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-small Cell Lung Cancers
Applicable Disease SitesLung
Drugs InvolvedNivolumab
Treatment TypeTreatment
ContactGreenebaum Comprehensive Cancer Center: Maha Khalil, PhD Phone:410-328-5009
Back to Protocol Listing